TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer

This study is set up as a phase I prospective, single center, device interventional pilot study carried in office setting under local anesthesia. It will assess the tolerance and safety of target fusion ablation of prostate cancer tumors using Laser Induced Thermal Therapy (TFA-LITT) guided by fusion imaging in men 50 to 80 years of age with low to intermediate risk prostate cancer Prostate Cancer is currently managed with in a discrete fashion where patients either enroll in active surveillance protocols (No intervention) or undergo full intervention via whole gland treatments - most commonl

Trial Details

NCT ID
NCT05698576
Phase
NA
Sponsor
Urological Research Network, LLC
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • TRANBERG® Transperineal Fusion Laser--Induced Thermal Therapy of Prostate Cancer (TPF-LITT)
Locations (sample)
  • Hialeah, Florida, United States|25.8576,-80.27811

Key Eligibility Criteria

  • Willing and able to sign informed consent
  • Subject is able and willing to complete all procedure and follow-up visits indicated in the protocol
  • Absence of urinary retention
  • Prostate volume: ≥ 18 and ≤ 100 cc, measured by transrectal ultrasound

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →